FibroScan®
Article | 12.05.2021
Blog and news
topic :
category :
status :
Article | 22.04.2021
FibroScan® 630 Expert: Complete, Non-invasive Solution Offers Effective Management and Risk Stratification for Patients with Cirrhosis and Portal Hypertension
Webinar | 10.04.2021
Strategies For Identification of NAFLD NASH in T2DM Using Non Invasive Diagnostic Tools
Article | 10.04.2021
Type 2 diabetes: search for « fatty liver »
Article | 10.04.2021
Interest of a liver exploration for an early diagnosis of NASH
Article | 10.04.2021
FibroScan® and the role of liver stiffness
Article | 10.04.2021
VCTE™& elastography
Webinar | 10.04.2021
Spleen Stiffness – The Noninvasive Alternative For Assessment of Portal Hypertension & Esophageal Varices Risk
Article | 09.04.2021
COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients
Article | 09.04.2021
FibroScan® Recommended for Hepatitis C Patients
Article | 09.04.2021
Echosens Observes National Drug and Alcohol Facts Week 2021
Article | 09.04.2021
Economic Analysis Model Suggests Screening People for Fibrosis With Non-Invasive Tests Cost-effective
Press Release | 09.04.2021
International NASH Day 2020
Article | 09.04.2021
Innovative FAST™ Score Helps Clinicians Address the Epidemic of Active Fibrotic NASH
Article | 09.04.2021